Abstract
Introduction: Depression in people living with HIV/AIDS is associated with poor health outcomes. Despite this, assessment of depressive symptoms is not a routine clinical practice in the care of people with HIV in Colombia. One reason could be the lack of validated depression screening scales for this population.Objective: To test the reliability and construct validity of the 20- and 10-item-Center for Epidemiological Studies Depression Scale in patients attending an HIV clinic in Cali, Colombia.Materials and methods: A non-random sample of 105 adults was enrolled. The 20 item-CES-D (CES-D-20) scale was administered twice: At baseline and 2-4 weeks later. We calculated the Cronbach’s alpha coefficient and the intraclass correlation coefficient. In addition, we used an exploratory and confirmatory factorial analysis, as well as the item response theory to assess the validity of the scale.Results: Most participants were men (73%), with a mean age of 40 years, 53% of whom had not completed high school. Cronbach’s coefficients were 0.92 and 0.94 at baseline and at the second interview, respectively. The intraclass correlation was 0.81 (95% CI: 0.72-0.88). Although all 20 items loaded distinctly in 4 factors, 5 items did not load as expected. The structure factor of the CES-D-20 was not confirmed, as 4 items had poor goodness of fit. The CES-D-10 appeared to perform better in this population. Conclusions: These results support the reliability and validity of the CES-D-10 instrument to screen for depressive symptoms in people living with HIV in Colombia.
Publisher
Instituto Nacional de Salud (Colombia)
Subject
General Biochemistry, Genetics and Molecular Biology
Reference51 articles.
1. 1. Murray CJ, López AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-504. https://doi.org/10.1016/ SOI 40-6736(96)07492-2
2. Depression, chronic diseases, and decrements in health: Results from the World Health Surveys.;Moussavi;Lancet,2007
3. 3. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547. https://doi.org/10.1371/journal. pmed.1001547
4. 4. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-lll-R psychiatric disorders in the United States; Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51:8-19. https://doi.Org/10.1001/archpsyc. 1994.03950010008002
5. 5. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, etal Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001 ;58:721 -8. https://doi.Org/10.1001/archpsyc.58.8.721
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献